All In Biotech

Drug Trial Radar · NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 900 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

900

Planned (sponsor's estimate)

Start

Nov 24, 2025

Primary completion

Jun 30, 2029

Study completion Jun 30, 2031

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
Collaborators
Prothena Biosciences Limited
First posted
Sep 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

Conditions

  • Parkinson's Disease

Interventions

  • PrasinezumabDrug

    Participants will receive Prasinezumab as an IV Infusion as per the schedule mentioned in the protocol.

  • PlaceboDrug

    Participants will receive Placebo as an IV Infusion per the schedule mentioned in the protocol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Confirmed Motor Progression Event on Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III ScoreTime frame: Up to at least Week 104

Locations

192 sites in 17 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Barrow Neurological Institute

    Phoenix, Arizona · Recruiting

  • Neurology Center of North Orange County

    Fullerton, California · Recruiting

  • UC San Diego

    La Jolla, California · Recruiting

  • Keck School of Medicine of USC

    Los Angeles, California · Recruiting

  • UCLA Neurology Outpatient Clinic

    Los Angeles, California · Recruiting

  • Parkinson?s Research Centers of America ? Palo Alto

    Palo Alto, California · Recruiting

  • Profound Research LLC at The Neurology Center of Southern California

    Pasadena, California · Recruiting

  • UCSF Weill Institute for Neurosciences

    San Francisco, California · Recruiting

  • Stanford Neuroscience Health Center (SNHC)

    Stanford, California · Recruiting

  • Rocky Mountain Movement Disorders

    Englewood, Colorado · Recruiting

  • Institute for Neurodegenerative Disorders

    New Haven, Connecticut · Recruiting

  • Georgetown University

    Washington D.C., District of Columbia · Recruiting

  • JEM Research LLC

    Atlantis, Florida · Recruiting

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida · Recruiting

  • K2 - Villages

    Lady Lake, Florida · Recruiting

  • K2 Medical Research-Maitland

    Maitland, Florida · Recruiting

  • Baptist Hospital of Miami

    Miami, Florida · Recruiting

  • Charter Research - Winter Park/Orlando

    Orlando, Florida · Recruiting

  • Advent Health Orlando

    Orlando, Florida · Recruiting

  • USF Parkinsons Disease and Movement Disorders Center

    Tampa, Florida · Recruiting

  • Grady Memorial Hospital

    Atlanta, Georgia · Recruiting

  • Hawaii Pacific Neuroscience

    Honolulu, Hawaii · Recruiting

  • Northwestern University Feinberg School Of Medicine

    Chicago, Illinois · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Quest Research Institute

    Farmington Hills, Michigan · Recruiting

  • Washington Uni School of Medicine

    St Louis, Missouri · Recruiting

  • Cleveland Clinic Lou Ruvo

    Las Vegas, Nevada · Recruiting

  • Renown Health

    Reno, Nevada · Recruiting

  • Hackensack University Medical Center;Department of Neurology, Neuroscience Institute

    Paramus, New Jersey · Recruiting

  • University of New Mexico

    Albuquerque, New Mexico · Recruiting

  • Dent Neurological Institute

    Amherst, New York · Recruiting

  • Parkinson's Research Centers of America - Long Island

    Commack, New York · Recruiting

  • Weill Cornell Medical College

    New York, New York · Recruiting

  • Columbia University Medical Center

    New York, New York · Recruiting

  • Asheville Neurology

    Asheville, North Carolina · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • NeuroCare Center

    Canton, Ohio · Recruiting

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

Showing 40 of 192 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.